JP7840859B2 - 子宮頸部細胞異常の治療に使用するための組成物 - Google Patents

子宮頸部細胞異常の治療に使用するための組成物

Info

Publication number
JP7840859B2
JP7840859B2 JP2022551024A JP2022551024A JP7840859B2 JP 7840859 B2 JP7840859 B2 JP 7840859B2 JP 2022551024 A JP2022551024 A JP 2022551024A JP 2022551024 A JP2022551024 A JP 2022551024A JP 7840859 B2 JP7840859 B2 JP 7840859B2
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
asc
use according
composition
change
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022551024A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023516153A5 (https=
JP2023516153A (ja
Inventor
ノルベルト フィッツ、
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SELO MEDICAL GmbH
Original Assignee
SELO MEDICAL GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SELO MEDICAL GmbH filed Critical SELO MEDICAL GmbH
Publication of JP2023516153A publication Critical patent/JP2023516153A/ja
Publication of JP2023516153A5 publication Critical patent/JP2023516153A5/ja
Application granted granted Critical
Publication of JP7840859B2 publication Critical patent/JP7840859B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2022551024A 2020-03-03 2021-03-03 子宮頸部細胞異常の治療に使用するための組成物 Active JP7840859B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20160817.1 2020-03-03
EP20160817.1A EP3875083A1 (en) 2020-03-03 2020-03-03 Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid
PCT/EP2021/055230 WO2021175877A1 (en) 2020-03-03 2021-03-03 Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid

Publications (3)

Publication Number Publication Date
JP2023516153A JP2023516153A (ja) 2023-04-18
JP2023516153A5 JP2023516153A5 (https=) 2026-03-16
JP7840859B2 true JP7840859B2 (ja) 2026-04-06

Family

ID=69770560

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022551024A Active JP7840859B2 (ja) 2020-03-03 2021-03-03 子宮頸部細胞異常の治療に使用するための組成物

Country Status (23)

Country Link
US (1) US20230092142A1 (https=)
EP (2) EP3875083A1 (https=)
JP (1) JP7840859B2 (https=)
CN (1) CN115279358A (https=)
AR (1) AR122387A1 (https=)
AU (1) AU2021231205B2 (https=)
BR (1) BR112022017436A2 (https=)
CL (1) CL2022002363A1 (https=)
CY (1) CY1126764T1 (https=)
ES (1) ES2976058T3 (https=)
HR (1) HRP20240374T1 (https=)
HU (1) HUE066384T2 (https=)
IL (1) IL296146A (https=)
MA (1) MA58262B1 (https=)
MD (1) MD4084788T2 (https=)
MX (1) MX2022010838A (https=)
PL (1) PL4084788T3 (https=)
RS (1) RS65349B1 (https=)
SM (1) SMT202400126T1 (https=)
TW (1) TW202146004A (https=)
UA (1) UA130108C2 (https=)
WO (1) WO2021175877A1 (https=)
ZA (1) ZA202208848B (https=)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014505708A (ja) 2011-02-16 2014-03-06 セロ メディカル ゲゼルシャフト ミット ベシュレンクテル ハフツング 子宮頚部の異形成または癌腫の治療用の亜セレン酸あるいは亜セレン酸イオン含有化合物を含有する医薬調製物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2406377C (en) 2000-05-10 2010-07-06 Okopharm Forschungs-Und Entwicklungs-Gmbh Method for reducing the surface area of silicon dioxide
AT412758B (de) 2000-06-05 2005-07-25 Vis Vitalis Lizenz & Handels Verwendung einer selenithältigen lösung zur behandlung viraler erkrankungen
AT412703B (de) 2001-12-04 2005-06-27 Vis Vitalis Lizenz & Handels Verwendung von selenithältigen präparaten zur topischen oder bukkalen anwendung
EP3616693A1 (en) * 2018-08-28 2020-03-04 Selo Medical GmbH Therapy of high-risk human papillomavirus infections

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014505708A (ja) 2011-02-16 2014-03-06 セロ メディカル ゲゼルシャフト ミット ベシュレンクテル ハフツング 子宮頚部の異形成または癌腫の治療用の亜セレン酸あるいは亜セレン酸イオン含有化合物を含有する医薬調製物

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Cancer Cytopathology，2011年，Vol.119, No.3，pp.158-166
Gynecologic Oncology，2011年，Vol.121，pp.505-509
日本臨床細胞学会雑誌，2011年，Vol.50, 補冊1号，p.182 Abstract No. O-2-11, O-2-12

Also Published As

Publication number Publication date
US20230092142A1 (en) 2023-03-23
EP3875083A1 (en) 2021-09-08
RS65349B1 (sr) 2024-04-30
CL2022002363A1 (es) 2023-03-31
ES2976058T3 (es) 2024-07-22
EP4084788A1 (en) 2022-11-09
WO2021175877A1 (en) 2021-09-10
CY1126764T1 (el) 2026-02-25
ZA202208848B (en) 2024-09-25
AU2021231205A1 (en) 2022-09-01
CN115279358A (zh) 2022-11-01
BR112022017436A2 (pt) 2022-10-18
EP4084788B1 (en) 2024-02-14
TW202146004A (zh) 2021-12-16
CA3167015A1 (en) 2021-09-10
AU2021231205B2 (en) 2026-02-26
MD4084788T2 (ro) 2024-06-30
IL296146A (en) 2022-11-01
MA58262B1 (fr) 2024-03-29
PL4084788T3 (pl) 2024-06-03
UA130108C2 (uk) 2025-11-12
JP2023516153A (ja) 2023-04-18
AR122387A1 (es) 2022-09-07
HUE066384T2 (hu) 2024-07-28
SMT202400126T1 (it) 2024-05-14
EP4084788C0 (en) 2024-02-14
MX2022010838A (es) 2022-09-27
HRP20240374T1 (hr) 2024-06-07

Similar Documents

Publication Publication Date Title
EP3603637B1 (en) Treatment of cancer and benign proliferative disorders caused by human papilloma virus
US20250281524A1 (en) Therapy of high-risk human papillomavirus infections
Sun et al. Study on human papillomavirus (HPV) infection, typing, peripheral blood immune factor expression and vaginal microenvironment balance in cervical cancer screening population
JP7840859B2 (ja) 子宮頸部細胞異常の治療に使用するための組成物
CA3167015C (en) Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid
EA048159B1 (ru) Композиция для применения в лечении аномалий цервикальных клеток, содержащая селенитовое соединение и кислоту
HK40074763B (en) Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid
HK40074763A (en) Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid
EA042677B1 (ru) Терапия папилломавирусных инфекций человека высокого риска
HK40045218B (en) Therapy of high-risk human papillomavirus infections
HK40045218A (en) Therapy of high-risk human papillomavirus infections
EA048333B1 (ru) Терапия папилломавирусных инфекций человека высокого риска
Dikkers et al. Recurrent Respiratory Papillomatosis and Human Papillomavirus
Huber et al. and Pedro-Antonio Regidor3
Hind Cytokeratin 19 significance in normal and HPV infected oral mucosa

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240227

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250218

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250512

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250815

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250909

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20251203

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20260306

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260317

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260325

R150 Certificate of patent or registration of utility model

Ref document number: 7840859

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150